Study of Durvalumab (MEDI4736) (Anti-PD-L1) and Trametinib (MEKi) in MSS Metastatic Colon Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Novartis
Related studies linked through entity extraction aliases.
Evaluating Low-dose Deferasirox (DFX) in Patients With Low-risk MDS Resistant or Relapsing After ESA Agents
- Status
- COMPLETED
- Phase
- PHASE2
Compassionate Use: Progressive Metastatic Castrate Resistant Prostate Cancer; Monotherapy Treatment With Trametinib
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has Spread
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Mechanism of Action of Anti-IL17 Therapy in Peripheral Spondyloarthritis
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)
- Status
- COMPLETED
- Phase
- PHASE1
Ruxolitinib vs Allogeneic SCT for Patients With Myelofibrosis According to Donor Availability
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Secukinumab Therapy for the Treatment of Moderate to Severe Plaque Psoriasis With Response Monitoring Using Optical Coherence Tomography (OCT).
- Status
- UNKNOWN
- Phase
- PHASE4
Pembrolizumab and Trametinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer and KRAS Gene Mutations
- Status
- COMPLETED
- Phase
- PHASE1
Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Study of EGF816 and Gefitinib in TKI-naïve EGFR-mutant Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
The African-PREDICT Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Neadjuvant Multi-agent Chemotherapy or Letrozole Plus Ribociclib in Luminal B/HER2-negative Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Muscle Wasting in Cancer (MWIC)
- Status
- COMPLETED
- Phase
- N/A
Exploratory Evaluation of Biomarkers Associated With Treatment Response to Cosentyx (Secukinumab) in Psoriasis Patients
- Status
- COMPLETED
- Phase
- N/A
Safety and Efficacy of Secukinumab in Mild Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
Treatment Plan for an Individual Patient With Pasireotide for Hyperinsulinemic Hypoglycemia
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1